Assenagon Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $27.4M | Sell |
|
|||||
|
2025
Q2 | $19.1M | Hold |
|
|||||
|
2025
Q1 | $25.1M | Sell |
|
|||||
|
2024
Q4 | $27.3M | Buy |
|
|||||
|
2024
Q3 | $8.97M | Buy |
|
|||||
|
2024
Q2 | $8.81M | Buy |
|
|||||
|
2024
Q1 | $6.61M | Sell |
|
|||||
|
2023
Q4 | $8.9M | Buy |
|
|||||
|
2023
Q3 | $5.67M | Buy |
|
|||||
|
2023
Q2 | $5.54M | Sell |
|
|||||
|
2023
Q1 | $7.17M | Buy |
|
|||||
|
2022
Q4 | $255K | Sell |
|
|||||
|
2022
Q3 | $484K | Sell |
|
|||||
|
2022
Q2 | $4.05M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $6.22M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.51M | Sell |
|
|||||
|
2020
Q2 | $2.64M | Buy |
|